Catumaxomab

Revision as of 23:34, 8 August 2012 by WikiBot (talk | contribs) (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Jump to navigation Jump to search

Template:Drugbox-mab

WikiDoc Resources for Catumaxomab

Articles

Most recent articles on Catumaxomab

Most cited articles on Catumaxomab

Review articles on Catumaxomab

Articles on Catumaxomab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Catumaxomab

Images of Catumaxomab

Photos of Catumaxomab

Podcasts & MP3s on Catumaxomab

Videos on Catumaxomab

Evidence Based Medicine

Cochrane Collaboration on Catumaxomab

Bandolier on Catumaxomab

TRIP on Catumaxomab

Clinical Trials

Ongoing Trials on Catumaxomab at Clinical Trials.gov

Trial results on Catumaxomab

Clinical Trials on Catumaxomab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Catumaxomab

NICE Guidance on Catumaxomab

NHS PRODIGY Guidance

FDA on Catumaxomab

CDC on Catumaxomab

Books

Books on Catumaxomab

News

Catumaxomab in the news

Be alerted to news on Catumaxomab

News trends on Catumaxomab

Commentary

Blogs on Catumaxomab

Definitions

Definitions of Catumaxomab

Patient Resources / Community

Patient resources on Catumaxomab

Discussion groups on Catumaxomab

Patient Handouts on Catumaxomab

Directions to Hospitals Treating Catumaxomab

Risk calculators and risk factors for Catumaxomab

Healthcare Provider Resources

Symptoms of Catumaxomab

Causes & Risk Factors for Catumaxomab

Diagnostic studies for Catumaxomab

Treatment of Catumaxomab

Continuing Medical Education (CME)

CME Programs on Catumaxomab

International

Catumaxomab en Espanol

Catumaxomab en Francais

Business

Catumaxomab in the Marketplace

Patents on Catumaxomab

Experimental / Informatics

List of terms related to Catumaxomab


Overview

Catumaxomab (removab®) is a rat-murine hybrid monoclonal antibody and which it's used to treat some cancers such as platinum-refractory ovarian cancer, malignant ascites, and gastric cancer. It binds to antigen CD3 and is also trifunctional. It is in clinical trials in the United States currently and is used in Europe.

It basically works by linking your T-lymphocytes with the cancer cells.


Template:Rat-murinehybridmonoclonals

Template:WS